KRYS — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

11.71

Margin Of Safety %

Put/Call OI Ratio

0.98

EPS Next Q Diff

0.03

EPS Last/This Y

0.93

EPS This/Next Y

1.22

Price

305.85

Target Price

401.25

Analyst Recom

1.25

Performance Q

-8

Upside

-16.6%

Beta

0.65

Ticker: KRYS

23 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-10-13	KRYS	321.17	1.17	1.15	6210
2026-10-14	KRYS	330.59	1.18	0.03	6204
2026-10-15	KRYS	329.88	1.15	0.07	6270
2026-10-16	KRYS	316.58	1.16	1.05	6240
2026-10-19	KRYS	320.27	1.51	0.00	5058
2026-10-20	KRYS	325.56	1.14	0.24	5722
2026-10-21	KRYS	322.14	1.13	1.00	5744
2026-10-22	KRYS	320.13	1.12	0.06	5750
2026-10-23	KRYS	311.32	1.12	0.01	5758
2026-10-26	KRYS	314.92	1.11	0.15	5799
2026-10-27	KRYS	320.87	1.10	0.03	5812
2026-10-28	KRYS	321.56	1.10	0.80	5825
2026-10-29	KRYS	324.27	1.10	2.72	5879
2026-10-30	KRYS	332.43	1.09	1.08	5911
2026-11-02	KRYS	295.74	1.10	0.37	5986
2026-11-03	KRYS	305	1.01	0.19	6448
2026-11-04	KRYS	310.81	1.01	0.36	6481
2026-11-05	KRYS	300.21	1.01	0.18	6468
2026-11-06	KRYS	300.71	1.01	0.12	6469
2026-11-09	KRYS	302.89	1.01	0.20	6481
2026-11-10	KRYS	306.56	1.00	1.67	6466
2026-11-11	KRYS	308.71	0.98	0.86	6531
2026-11-12	KRYS	305.76	0.98	999.99	6541
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

23 items 1 of 1

23 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-10-13	KRYS	321.67	-25.6	117.7	7.74
2026-10-14	KRYS	330.57	-25.6	139.2	7.74
2026-10-15	KRYS	329.85	-25.6	138.5	7.74
2026-10-16	KRYS	316.61	-26.0	114.2	7.70
2026-10-19	KRYS	320.29	-26.0	132.8	7.70
2026-10-20	KRYS	320.29	-26.0	132.8	7.70
2026-10-21	KRYS	325.60	-27.3	138.8	7.62
2026-10-22	KRYS	320.15	-27.3	126.5	7.62
2026-10-23	KRYS	311.50	-27.3	119.1	7.62
2026-10-26	KRYS	313.70	-27.9	131.3	7.59
2026-10-27	KRYS	320.62	-27.9	136.7	7.59
2026-10-28	KRYS	321.55	-27.9	137.7	7.59
2026-10-29	KRYS	324.27	-27.9	131.7	7.59
2026-10-30	KRYS	331.67	-27.9	136.5	7.59
2026-11-02	KRYS	295.97	-27.9	89.4	7.59
2026-11-03	KRYS	304.96	-27.9	70.0	7.59
2026-11-04	KRYS	310.77	56.1	105.8	8.05
2026-11-05	KRYS	300.17	56.1	86.5	8.05
2026-11-06	KRYS	300.83	35.4	136.5	8.00
2026-11-09	KRYS	302.97	35.4	138.5	8.00
2026-11-10	KRYS	306.58	30.6	140.3	8.01
2026-11-11	KRYS	308.82	30.6	138.4	8.01
2026-11-12	KRYS	305.85	30.6	131.7	8.01
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

23 items 1 of 1

22 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-10-13	KRYS	-3.37	3.88	13.38
2026-10-14	KRYS	-3.37	3.88	13.38
2026-10-15	KRYS	-3.37	3.88	13.38
2026-10-16	KRYS	-3.37	3.88	13.38
2026-10-19	KRYS	-3.37	3.87	13.38
2026-10-20	KRYS	-3.37	3.87	13.38
2026-10-21	KRYS	-3.37	3.87	13.38
2026-10-22	KRYS	-3.37	3.87	13.38
2026-10-23	KRYS	-3.37	3.87	13.38
2026-10-26	KRYS	-3.37	3.78	13.38
2026-10-27	KRYS	-3.37	3.78	11.31
2026-10-28	KRYS	-3.37	3.78	11.31
2026-10-29	KRYS	-3.37	3.78	11.31
2026-10-30	KRYS	-3.37	3.78	11.31
2026-11-02	KRYS	-3.37	0.24	11.31
2026-11-03	KRYS	-3.37	0.24	11.31
2026-11-05	KRYS	-3.37	0.24	11.29
2026-11-06	KRYS	-3.37	0.24	11.29
2026-11-09	KRYS	-3.37	-0.74	11.29
2026-11-10	KRYS	-3.37	-0.74	11.29
2026-11-11	KRYS	-3.37	-0.74	11.71
2026-11-12	KRYS	-3.37	-0.74	11.71
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

22 items 1 of 1

Last Quarter Act. EPS

2.05

Avg. EPS Est. Current Quarter

1.92

Avg. EPS Est. Next Quarter

2.08

Insider Transactions

-3.37

Institutional Transactions

-0.74

Beta

0.65

Average Sales Estimate Current Quarter

129

Average Sales Estimate Next Quarter

139

Fair Value

362.02

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

-44.5

Target Price

401.25

P/E

41.51

Forward P/E

32.99

PEG

1.68

P/S

19.27

P/B

6.31

P/Free Cash Flow

29.21

EPS

7.36

Average EPS Est. Cur. Y

8.01

EPS Next Y. (Est.)

9.23

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

47.91

Relative Volume

0.56

Return on Equity vs Sector %

-10.7

Return on Equity vs Industry %

8.7

EPS 1 7Days Diff

0.4

EPS 1 30Days Diff

0.15

EBIT Estimation

131.7

◆ KRYS Healthcare

$305.68

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

6/20

Pullback

17/25

Volume

8/15

Valuation

16/20

TP/AR

4/10

Options

3/10

RSI

43.3

Range 1M

44.2%

Sup Dist

0.4%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

2/25

Growth

16/30

Estimates

7/20

Inst/Vol

1/15

Options

4/10

EPS Yr

12.2%

EPS NY

20.8%

52W%

59%

💎

Long-Term Value

Quality companies, undervalued

WATCH

🟡 HOLD +14.6% upside

Quality

21/30

Valuation

10/30

Growth

15/25

Stability

7/10

LT Trend

2/5

Upside

+14.6%

Quality

MoS

18%

KRYS — P/E HistoricalBiotechnology

Krystal Biotech, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 295

Krystal Biotech, Inc., a commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States. The company commercializes VYJUVEK (beremagene geperpavec-svdt, or B-VEC) for the treatment of dystrophic epidermolysis bullosa (DEB). It also develops KB803 for ocular complications of dystrophic epidermolysis bullosa; KB801 for neurotrophic keratitis; KB407, which is in Phase 1 clinical trials for treating cystic fibrosis; KB111 for Hailey-Hailey disease; KB707 for solid tumors; KB304 for dynamic wrinkles; KB707 that is in Phase 1/2 clinical trials for the treatment of anti-PD-1 relapsed/refractory; KB408, which is in Phase 1 clinical trials for treating Alpha-1 antitrypsin deficiency; and KB301 that is in Phase 2 clinical trials for treating aesthetic skin conditions, as well as in open label study with ophthalmic B-VEC for treating for ocular complications of deb. Krystal Biotech, Inc. was founded in 2016 and is headquartered in Pittsburgh, Pennsylvania.

KRYS

Latest News

—

Caricamento notizie per KRYS…

stock quote shares KRYS – Krystal Biotech, Inc. Stock Price stock today

news today KRYS – Krystal Biotech, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch KRYS – Krystal Biotech, Inc. yahoo finance google finance

stock history KRYS – Krystal Biotech, Inc. invest stock market

stock prices KRYS premarket after hours

ticker KRYS fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: KRYS

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y